Use of 18F-fluorodeoxyglucose positron emission tomography to change management and assess response to therapy in post-transplant extramedullary relapse of acute myeloid leukaemia

Internal Medicine Journal

Volumn 40, Issue 6, 2010, Pages 466-467

  Gunawardana, D H ^a   Grigg, A ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; FLUORODEOXYGLUCOSE F 18; METHOTREXATE; MITOXANTRONE;

ADULT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LETTER; MALE; MYELOID LEUKEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELAPSE; TREATMENT RESPONSE;

ADULT; DISEASE MANAGEMENT; FLUORODEOXYGLUCOSE F18; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATIONS; RECURRENCE; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77953854175     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2010.02246.x     Document Type: Letter

References (7)

1. Hillner BE, Siegel BA, Liu D, Shields AF, Gareen IF, Hanna L et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol 2008 26 : 2155 2161.
2. Haioun C, Itti E, Rahmouni A, Brice P, Rain JD, Belhadj K et al. [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 2005 106 : 1376 1381.
3. Hutchings M, Loft A, Hansen M, Pedersen LM, Buhl T, Jurlander J et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 2006 107 : 52 9.
4. Kuenzle K, Taverna C, Steinert HC. Detection of extramedullary infiltrates in acute myelogenous leukemia with whole-body positron emission tomography and 2-deoxy-2-[18F]-fluoro-D-glucose. Mol Imaging Biol 2002 4 : 179 183.
5. Mantzarides M, Bonardel G, Fagot T, Gontier E, Soret M, Revel TD et al. Granulocytic sarcomas evaluated with F-18-fluorodeoxyglucose PET. Clin Nucl Med 2008 33 : 115 117.
6. Rao S, Langston A, Galt JR, Halkar RK. Extramedullary acute myeloid leukemia and the use of FDG-PET/CT. Clin Nucl Med 2009 34 : 365 366.
7. Chong G, Byrnes G, Szer J, Grigg A. Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy. Bone Marrow Transplant 2000 26 : 1011 1015.